Christopher Kabrhel, MD, MPH

Christopher Kabrhel, MD, MPH, is a practicing emergency physician at Massachusetts General Hospital with more than 20 years of experience performing research into the epidemiology, diagnosis, risk stratification, and treatment of cardiovascular disease, specifically venous thromboembolism (PE and DVT). He is the Director of the Center for Vascular Emergencies, a multidisciplinary research center housed within the MGH Department of Emergency Medicine that focuses on the diagnosis and risk-stratification of patients with venous thromboembolism, and the development of novel care delivery methods for patients with acute PE. In 2012, Dr. Kabrhel co-founded the MGH Pulmonary Embolism Response Team (PERT), the first such team in the world, and later, the PERT Consortium. He also coordinates venous thromboembolism research for the Nurses' Health Study at Channing Network Medicine at the Health Professionals Follow Up Study at the TH Chan Harvard School of Public Health, where he focuses on epidemiology and population risk factors for VTE. To further his work, he co-founded the International Network for Venous Thromboembolism Research which focuses on the genetic epidemiology of VTE. His recent work explores the biological mechanisms of thrombosis and the integration of high-throughput -omics with clinical data and machine learning to facilitate biomarker discovery. Dr. Kabrhel is a professor of emergency medicine at Harvard Medical School, Honorary Senior Lecturer at Queen Mary University in London, Honorary Professor of Clinical Medicine at Aarhus University, and the MGH Endowed Chair in Emergency Medicine.